Risks associated with melamine and related triazine contamination of food

Emerging Health Threats Journal

Volumn 3, Issue 1, 2010, Pages

  Baynes, Ronald E ^a   Riviere, Jim E ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Food; Melamine; Pharmacokinetics; Residue; Triazine

Indexed keywords

CYANURIC ACID; MELAMINE; TRIAZINE DERIVATIVE;

ANIMAL FOOD; DAIRY PRODUCT; FOOD CONTAMINATION; FOOD POISONING; FOOD SAFETY; HEALTH HAZARD; HEMATURIA; HUMAN; KIDNEY CLEARANCE; KIDNEY FAILURE; LIVESTOCK; MORTALITY; NEPHROLITHIASIS; NEPHROTOXICITY; NONHUMAN; PUBLIC HEALTH PROBLEM; REVIEW; RISK ASSESSMENT; TOXICITY TESTING; TOXICOKINETICS;

EID: 77957870257     PISSN: 17528550     EISSN: None     Source Type: Journal    
DOI: 10.3134/ehtj.10.005     Document Type: Review

References (50)

1. Jutzi K, Cook AM, Hütter R. The degradative pathway of the s-triazine melamine. The steps to ring cleavage. Biochem J. 1982;208(3):679-84.
2. Seffernick JL, de Souza ML, Sadowsky MJ, Wackett LP. Melamine deaminase and atrazine chlorohydrolase: 98 percent identical but functionally different. J. Bacteriol. 2001;183(8):2405-2410.
3. Bielejewska AG, Marjo CE, Prins LJ, Timmerman P, de Jong F, Reinhoudt DN. Thermodynamic stabilities of linear and crinkled tapes and cyclic rosettes in melamine - cyanurate assemblies: a model description. J Am Chem Soc. 2001; 123(31):7518-7533. (Pubitemid 32903919)
4. Xu W, Dong MD, Gersen H, Rauls E, Vazquez-Campos S, Crego-Calama M, Reinhoudt DN, Stensgaard I, Laegsgaard E, Linderoth TR, Besenbacher F. Cyanuric acid and melamineon Au(111): Structure and energetics of hydrogen-bonded networks. Small, 2007; 3: 854-858.
5. Riviere JE. Comparative Pharmacokinetics: Principles, Techniques, and Applications. Iowa State Press, Ames, (IO); 2000.
6. Reddy MB, Yang RSH, Clewell HJ, Anderson ME. Physiologically Based Pharmacokinetic Modeling. John Wiley and Sons., Inc. Hoboken, NJ; 2005.
7. rd Edition, Lippincott Williams and Wilkins, Philadelphia, PA; 2003
8. Ingelfinger JR. Melamine and the global implications of food contamination. N. Engl. J. Med. 2008;359: 2745-2748.
9. th, 2008.
10. Lam HS, Ng, PC. Renal screening in children after exposure to low dose melamine in Hong Kong: cross sectional study. Brit. Med. J. 2008;337: 1-4.
11. United States Food and Drug Administration (US FDA). Interim Melamine and Analogues Safety/Risk Assessment, May 24, 2007. Available from: www.fda.gov/OHRMS/DOCKETS/98fr/07n-0208-ra00001.pdf.
12. Organization for Economic Cooperation and Development (OECD). OECD SIDS Analysis UNEP Publications: Melamine; 2002. Available from: http://www.inchem. org/documents/sids/sids/108781.pdf
13. Lipschitz WL, Stokey E. The mode of action of three new diuretics: melamine, adenine and formoguanamine. J. Pharmacol. Exp. Therap. 1945;83: 235-249.
14. National Toxicology Program (NTP). Carcinogenesis Bioassay of Melamine (CAS No. 108-78-1) in F344/N Rats and B6C3F1 Mice (Feed Study) NTP TR 245:1-171. NIH Publication No. 83-2501. 1983.
15. Ogasawara H, Imaida K, Ishiwata H, Toyoda, K., Kawanishi, T., Uneyama, C., Hayashi, S., Takahashi, M., Hayashi, Y. Urinary bladder carcinogenesis induced by melamine in F344 male rats: correlation between carcinogenicity and urolith formation. Carcinogenesis 1995;16(11), 2773-2777.
16. Melnick RF, Boorman GA, Haseman JK, Montali RJ, Huff J. Urolithiasis and bladder carcinogenicity of melamine in rodents. Toxicol. Appl. Pharmacol. 1984; 72 (2): 292-303.
17. Shelby M.D, Erexson GL, Hook GJ, Tice RR Evaluation of a three-exposure mouse bone marrow micronucleus protocol: results with 49 chemicals. Environmental and Molecular Mutagenesis. 1993, 21(2): 160-179.
18. Cremonezzi DC, Silva RA, Díaz MP, Valentich MA, Eynard AR. Dietary polyunsatured fatty acids (PUFA) differentially modulate melamine-induced preneoplastic urothelial proliferation and apoptosis in mice. Prostagl. Leuk. Essent. Fatty Acids. 2001, 64: 151-159.
19. Cremonezzi DC, Diaz MP, Valentich MA, Eynard AR. Neoplastic and preneoplastic lesions induced by melamine in rat urothelium are modulated by dietary polyunsaturated fatty acids. Food. Chem. Toxicol. 2004, 42: 1999-2007.
20. Brown CA, Jeong KS, Poppenga RH, Puschner B, Miller DM, Ellis AE, Kang KI,Sum S, Cistola AM, Brown SA. Outbreaks of renal failure associated with melamine and cyanuric acid in dogs and cats in 2004 and 2007. J. Vet. Diagn. Invest. 2007;19: 525-531.
21. Burns K. Recall shines spotlight on pet foods. J. Am. Vet. Med. Assoc. 2007; 230(9), 1285-1286.
22. Burns K. Events leading to the major recall of pet foods. J. Am. Vet. Med. Assoc 2007; 230(11), 1600-1620.
23. Puschner B, Poppenga, RH, Lowenstine LJ, Filigenzi MS, Pesavento PA. Assessment of melamine and cyanuric acid toxicity in cats. J. Vet. Diag. Investig. 2007;19: 616-624.
24. Thompson ME, Lewin-Smith MR, Kalasinsky VF, Pizzolato KM, Fleetwood ML, Mcelhaney MR, Johnson TO. Characterization of melamine-containing and calcium oxalate crystals in three dogs with suspected pet food-induced nephrotoxicosis. Vet. Path. 2008;45: 417-426.
25. Clark R. Melamine crystalluria in sheep. J. S Afri Vet. Med. Assoc., 1966; 37:349-351.
26. Reimschuessel R, Gieseker CM, Miller RA, Ward J, Boehmer J, Rummel N, Heller DN, Nochetto C, de Alwis GK, Bataller N, Andersen WC, Turnipseed SB, Karbiwnyk CM, Satzger RD, Crowe JB, Wilber NR, Reinhard MK, Roberts JF, Witkowski MR. Evaluation of the renal effects of experimental feeding of melamine and cyanuric acid to fish and pigs. Am. J. Vet. Res. 2008;69: 1217-1228.
27. Dobson RL, Motlagh S, Quijano M, Cambron RT, Baker TR, Pullen AM, Regg BT, Bigalow-Kern AS, Vennard T, Fix A, Reimschuessel R, Overmann G, Shan Y, Daston GP. Identification and characterization of toxicity of contaminants in pet food leading to an outbreak of renal toxicity in cats and dogs. Toxicol. Sci. 2008;106: 251-262.
28. Perazella MA. Crystal-induced acute renal failure. Am. J. Med. 1999;106: 459-465.
29. Yarlagadda SG, Perazella MA. Drug-induced crystal nephropathy: an update. Summary Expert Opinion on Drug Safety. 2008;7: 147-158.
30. Khan SR. Crystal-induced inflammation of the kidneys: results from human studies, animal models, and tissue-culture studies. Clin. Exp. Nephrol. 2004;8: 75-88.
31. Khan KNM, Sellers RS. Risk assessment for selected therapeutics. In: (Eds. Tarloff, JB, Lash LH. Toxicology of the Kidney, CRC Press, Boca Raton, Fl.; 2004; Chapter 27, pp.1133-1162.
32. Guan N, Fan Q, Ding J, Zhao Y, Lu J, Ai Y, Xu G, Zhu S, Yao C, Jiang L, Miao J, Zhang H, Zhao D, Liu X, Yao Y. Melamine-Contaminated Powdered Formula and Urolithiasis in Young Children. NE. J. Med., 2009, 360:1-8
33. Lam CW, Lan L, Che X,Tam S, Sai-Yin Wong S, Chen Y, Jin J, Tao SH, Tang XM, Yuen KY, Kwong-Hang Tam P. Diagnosis and spectrum of melamine-related renal disease: Plausible mechanism of stone formation in humans. Clinica Chimica Acta 2009 (in press).
34. Mast RW, Jeffcoat AR, Sadler BM, Kraska RC. Friedman, M.A. Metabolism, disposition and excretion of [14C]melamine in male Fischer 344 rats. Food Chem. Toxicol. 1983;21(6), 807-810.
35. Sugita T, Ishiwata H., Maekawa A. Intestinal absorption and urinary excretion of melamine in male Wistar rats. J. Food Hyg. Soc. Japan. 1991;32: 439-443.
36. Baynes RE, Smith G, Mason SE, Barrett E, Barlow BM, Riviere JE.Pharmacokinetics of melamine in pigs following intravenous administration. Food Chem, Toxicol. 2008;46(3): 1196-200.
37. Smith JL, Wishnok JS, Deen WM. Metabolism and excretion of methyamines in rats. Toxicol. Appl Pharmacol. 1994;125, 296-308.
38. Gootman PM. Cardiovascular System. In: Pond WG, Mersmann HJ, editors. Biology of the Domestic Pig,. Cornell University Press, Ithaca, (NY), 2001; pp. 533-559.
39. United States Department of Agriculture (USDA). Disposition of hogs and chickens from farms identified as having received pet food scraps contaminated with melamine and melamine-related compounds and offered for slaughter. Federal Register, 2007;Vol. 72, No.103, Food Safety Inspection Service, Docket No. FSIS 2007-0018.
40. Shelton DR, Karns JS, McCarty GW, Durham DR. Metabolism of Melamine by Klebsiella terragena. Appl. Environ. Microbiol. 1997;63: 2832-2835.
41. Hammond BG, Barbee SJ, Inoue T, Ishida N, Levinskas GJ, Stevens MW, Wheeler AG, Cascieri T. A review of toxicology studies on cyanurate and its chlorinated derivatives. Environ Health Perspect. 1986;69:287-292. (Pubitemid 17220565)
42. Corley RA, Wilson DM, Hard GC, Stebbins KE, Bartels MJ, Soelberg JJ, Dryzga MD, Gingell R, McMartin KE, Snellings WM. Dosimetry considerations in the enhanced sensitivity of male Wistar rats to chronic ethylene glycol-induced nephrotoxicity. 2008;Toxicol. Appl. Pharmacol. 228: 165-178.
43. Cruzan G, Corley RA, Hard GC, Mertens JJ, McMartin KE, Snellings WM, Gingell R, Deyo JA. Subchronic toxicity of ethylene glycol in Wistar and F-344 rats related to metabolism and clearance of metabolites. Toxicol. Sci. 2004;81: 502-511.
44. Boer P, Prenen JA, Koomans HA, Dorhout Mees EJ. Fractional oxalate clearance insubjects with normal and impaired renal function. Nephron. 1985; 41: 78-81. (Pubitemid 15006038)
45. McIntosh GH, Belling GB. (1975). An isotopic study of oxalate excretion in sheep. Aust. J. Exp. Biol. Med. Sci. 53: 479-487.
46. Cattell WR, Spencer AG, Taylor GW, Watts RWE. The mechanism of the renal excretion of oxalate in the dog. Clin. Sci. 1962;22: 43-51.
47. Buur J, Baynes RE, Riviere JE. Estimating meat withdrawal times in pigs exposed to melamine contaminated feed using a physiologically based pharmacokinetic model. Reg. Pharmacol. Toxicol. 2008;51: 324-331.
48. Filigenzi MS, Tor ER, Poppenga RH, Aston LA, Puschner B. The determination of melamine in muscle tissue by liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass. Spectrom. 2007;21: 4027-4032.
49. Garber EA. Detection of melamine using commercial enzyme-linked immunosorbent assay technology. J. Food Prot. 2008;71: 590-594. (Pubitemid 351354710)
50. Vail T, Jones P, Sparkman O, David D. Rapid and unambiguous identification of melamine in contaminated pet food based on mass spectrometry with four degrees of confirmation. J. Anal. Toxicol. 2007. 31: 304-312.